Cigna Corp (CI)

279.19
+3.96 (1.44%)
NYSE · Last Trade: Jan 2nd, 1:08 PM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close275.23
Open276.66
Bid279.09
Ask279.25
Day's Range274.00 - 280.50
52 Week Range239.51 - 350.00
Volume450,354
Market Cap94.95B
PE Ratio (TTM)12.35
EPS (TTM)22.6
Dividend & Yield6.040 (2.16%)
1 Month Average Volume1,554,668

Chart

About Cigna Corp (CI)

Cigna Corporation is a global health service company that provides a comprehensive range of health insurance products and services. The company operates across various sectors, including medical, dental, disability, life, and accident insurance, offering coverage to individuals and families, as well as employer-sponsored group plans. Additionally, Cigna delivers integrated health services, such as pharmacy management, behavioral health support, and wellness programs, focusing on improving health outcomes and enhancing the overall well-being of its members. Through its innovative approaches, Cigna aims to create a seamless healthcare experience while addressing the diverse needs of its customers. Read More

News & Press Releases

BofA Unveils Q1 2026 Top Stock Picks: High-Conviction Bets on AI Infrastructure and Health Care Valuations
As the opening bells of 2026 ring across Wall Street, Bank of America Securities has released its highly anticipated "Top 10 U.S. Stock Ideas for Q1 2026." The report, a cornerstone for institutional strategy at the start of the year, arrives at a moment of heightened market sensitivity, as
Via MarketMinute · January 2, 2026
The GLP-1 Pricing Revolution: How Novo Nordisk and Eli Lilly Redefined the Weight-Loss Market for 2026
As the calendar turns to 2026, the landscape for weight-loss and diabetes medication has been fundamentally transformed. What began two years ago as a "wild west" of $1,000-a-month list prices and chronic shortages has evolved into a highly competitive, government-influenced market where affordability and accessibility have finally taken center
Via MarketMinute · January 2, 2026
What Does the Market Think About The Cigna Group?benzinga.com
Via Benzinga · January 1, 2026
Abbott Laboratories (ABT): Buy, Sell, or Hold Post Q3 Earnings?
Over the past six months, Abbott Laboratories’s shares (currently trading at $125.45) have posted a disappointing 7.9% loss, well below the S&P 500’s 11.2% gain. This may have investors wondering how to approach the situation.
Via StockStory · December 31, 2025
The Great Unbundling: How Federal Scrutiny is Dismantling the PBM Profit Machine
The long-standing dominance of Pharmacy Benefit Managers (PBMs) in the American healthcare system has reached a critical inflection point as 2025 draws to a close. For decades, these "middlemen" operated in the shadows, negotiating drug prices and rebates with manufacturers while managing prescription benefits for millions. However, a relentless wave
Via MarketMinute · December 31, 2025
Cigna Group (CI) Secures ‘Buy’ Upgrades as Analysts Dismiss PBM Regulatory Fears as Market Overreaction
As the curtain closes on 2025, the investment community is witnessing a significant shift in sentiment regarding the managed care sector. Cigna Group (NYSE: CI) has become the centerpiece of this narrative, receiving a wave of analyst upgrades to ‘Buy’ in the final weeks of December. Market experts are increasingly
Via MarketMinute · December 31, 2025
Dolce MD Offers Comprehensive Concierge Primary Care Services in Laguna Beach, CA
Name Dolce MD Contact name Dr. John Sanguedolce Contact phone (949) 209-9266 Contact address 310 Glenneyre St City Laguna Beach State California Zip 92651 Country USA Url https://dolcemd.com/
Via GetFeatured · December 31, 2025
Here's How Much You Would Have Made Owning Cigna Group Stock In The Last 20 Yearsbenzinga.com
Via Benzinga · December 29, 2025
Chubb Limited (CB) Deep Dive: The Global Risk Machine in 2025
As of December 18, 2025, Chubb Limited (NYSE: CB) stands as the preeminent titan of the global property and casualty (P&C) insurance landscape. With a market capitalization surging toward $120 billion and a reputation for ruthless underwriting discipline, the Zurich-domiciled insurer has become a cornerstone of institutional portfolios—most notably that of Warren Buffett’s Berkshire Hathaway. [...]
Via PredictStreet · December 18, 2025
Bristol Myers Squibb (BMS): Navigating the Patent Cliff with a Renewed Pipeline and Strategic Acquisitions
Date: December 15, 2025 1. Introduction Bristol Myers Squibb (BMS) (NYSE: BMY) is a global biopharmaceutical powerhouse focused on discovering, developing, manufacturing, and distributing innovative medicines for serious diseases. As of December 15, 2025, BMS stands at a critical juncture, balancing the impending "patent cliff" for several of its blockbuster drugs with a strategically diversified [...]
Via PredictStreet · December 15, 2025
2 Reasons to Like CI (and 1 Not So Much)
Over the last six months, Cigna’s shares have sunk to $276.25, producing a disappointing 12.1% loss - a stark contrast to the S&P 500’s 13% gain. This may have investors wondering how to approach the situation.
Via StockStory · December 18, 2025
Cigna Offers Cleaner Growth Than Other Health Insurers, Says Analystbenzinga.com
BofA outlines risks and upside for managed care stocks, favoring Cigna and Alignment while flagging Medicare and Medicaid uncertainty.
Via Benzinga · December 17, 2025
Humana, Molina Jump As House GOP Revolt Reignites Fight To Extend Obamacare Subsidies — Retail Warns ‘Healthcare Wreck’stocktwits.com
Health insurance stocks split after a House GOP revolt revived debate over ACA subsidies, while a year-end extension was ruled out.
Via Stocktwits · December 17, 2025
Molina Healthcare (MOH): Buy, Sell, or Hold Post Q3 Earnings?
What a brutal six months it’s been for Molina Healthcare. The stock has dropped 42.1% and now trades at $168.08, rattling many shareholders. This was partly due to its softer quarterly results and might have investors contemplating their next move.
Via StockStory · December 15, 2025
CI Investors Have Opportunity to Join The Cigna Group Fraud Investigation with the Schall Law Firm
LOS ANGELES, Dec. 10, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of The Cigna Group (“Cigna” or “the Company”) (NYSE: CI) for violations of the securities laws.
By Schall Law · Via GlobeNewswire · December 10, 2025
Meet the 2.5% Yield Dividend Stock That Could Soar in 2026fool.com
UnitedHealth Group raised its dividend in each of the last 16 years.
Via The Motley Fool · December 9, 2025
The JOLTS Report: A Cooling Labor Market Ignites Rate Cut Hopes Amidst Economic Uncertainty
The latest Job Openings and Labor Turnover Survey (JOLTS) data, released on December 9, 2025, for the month of October, presents a nuanced picture of the U.S. labor market. While a slight uptick in job openings might offer a glimmer of resilience, the overarching trends of stagnant hiring and
Via MarketMinute · December 9, 2025
HIAAH Partners with Alary Health Spa to Deliver Holistic Wellness: Integrating Mental Health with Rejuvenation and Total Body Vitality
HIAAH announces a strategic partnership with Alary Health Spa in New York’s Hudson Valley, expanding access to advanced clinical wellness services that complement mental health care.
Via Press Release Distribution Service · December 8, 2025
From Ivy League to Italian Vines: New Novel Captures the Ultimate Life Transformation
MARIETTA, GA - What does it truly take to trade the American dream for a richer life under the Tuscan sun? Thomas J. Celi answers this question in his sweeping new novel, AMERICAN COUPLE IN TUSCANY, released this week by Author's Tranquility Press.
Via AB Newswire · December 3, 2025
CI Investors Have Opportunity to Join The Cigna Group Fraud Investigation with the Schall Law Firm
LOS ANGELES, Dec. 03, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of The Cigna Group (“Cigna” or “the Company”) (NYSE: CI) for violations of the securities laws.
By Schall Law · Via GlobeNewswire · December 3, 2025
A Look Into Cigna Group Inc's Price Over Earningsbenzinga.com
Via Benzinga · December 2, 2025
CI Investors Have Opportunity to Join The Cigna Group Fraud Investigation with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of The Cigna Group (“Cigna” or “the Company”) (NYSE: CI) for violations of the securities laws.
By The Schall Law Firm · Via Business Wire · December 2, 2025
If You Invested $100 In Cigna Group Stock 20 Years Ago, You Would Have This Much Todaybenzinga.com
Via Benzinga · December 2, 2025
Is Cigna Stock Underperforming the Nasdaq?
Even though Cigna has lagged behind the broader Nasdaq Composite over the past year, Wall Street analysts remain bullish about the stock’s prospects.
Via Barchart.com · November 28, 2025
Is Elevance Health Stock Outperforming the Nasdaq?
Elevance Health has outpaced the Nasdaq Composite in recent months, and analysts remain optimistic about the stock’s prospects.
Via Barchart.com · November 26, 2025